AACI’s CRI annual meeting goes virtual

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Association of American Cancer Institutes’ Clinical Research Innovation program has moved its July 7-8 annual meeting to a virtual format.

“The health and well-being of AACI meeting attendees, exhibitors, and cancer center patients is our top priority,” AACI said in a statement. “As we plan our 2020 meetings, we are closely monitoring the coronavirus pandemic—particularly the impact of COVID-19 on travel and professional conferences.

“We believe this decision will allow us to deliver the innovative, quality education our members expect from the CRI annual meeting, while prioritizing the health and safety of attendees.”

The association said it plans to announce information on registration and virtual sessions in the coming weeks.

Table of Contents

YOU MAY BE INTERESTED IN

With the recent FDA approval of daratumumab for high-risk smoldering multiple myeloma, the moment is ripe to revisit the evolution of our understanding of smoldering multiple myeloma. This development not only underscores the growing recognition of early intervention but also invites a broader reflection on the biological insights and therapeutic strategies that have shaped—and continue to shape—this transitional disease state.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login